ENTITY: - **Veracyte**
DATE: 13-03-2026

**Forensic Audit Memo – Veracyte (Genomic Diagnostics)**

1. **Objective:** Assess data integrity, regulatory compliance, and financial reporting accuracy in Veracyte’s genomic diagnostic processes.
2. **Scope:** Review clinical sample handling, genomic data validation, billing practices, and third-party vendor relationships.
3. **Methodology:** Conduct forensic data analysis, document examination, and interviews with key personnel.
4. **Next Steps:** Present preliminary findings to leadership; escalate material discrepancies for further investigation.

*Confidential – For Internal Use Only*

[NOTARIZED BY 2A AGENCY]